294 related articles for article (PubMed ID: 18931305)
1. Functional recognition of a distinct receptor preferential for leukotriene E4 in mice lacking the cysteinyl leukotriene 1 and 2 receptors.
Maekawa A; Kanaoka Y; Xing W; Austen KF
Proc Natl Acad Sci U S A; 2008 Oct; 105(43):16695-700. PubMed ID: 18931305
[TBL] [Abstract][Full Text] [Related]
2. An alternative pathway for metabolism of leukotriene D(4): effects on contractions to cysteinyl-leukotrienes in the guinea-pig trachea.
Bäck M; Kumlin M; Cotgreave IA; Dahlén SE
Br J Pharmacol; 2001 Aug; 133(7):1134-44. PubMed ID: 11487525
[TBL] [Abstract][Full Text] [Related]
3. The leukotriene E4 puzzle: finding the missing pieces and revealing the pathobiologic implications.
Austen KF; Maekawa A; Kanaoka Y; Boyce JA
J Allergy Clin Immunol; 2009 Sep; 124(3):406-14; quiz 415-6. PubMed ID: 19647860
[TBL] [Abstract][Full Text] [Related]
4. Pharmacological evidence for a novel cysteinyl-leukotriene receptor subtype in human pulmonary artery smooth muscle.
Walch L; Norel X; Bäck M; Gascard JP; Dahlén SE; Brink C
Br J Pharmacol; 2002 Dec; 137(8):1339-45. PubMed ID: 12466244
[TBL] [Abstract][Full Text] [Related]
5. Differential signaling of cysteinyl leukotrienes and a novel cysteinyl leukotriene receptor 2 (CysLT₂) agonist, N-methyl-leukotriene C₄, in calcium reporter and β arrestin assays.
Yan D; Stocco R; Sawyer N; Nesheim ME; Abramovitz M; Funk CD
Mol Pharmacol; 2011 Feb; 79(2):270-8. PubMed ID: 21078884
[TBL] [Abstract][Full Text] [Related]
6. Studies of receptors and modulatory mechanisms in functional responses to cysteinyl-leukotrienes in smooth muscle.
Bäck M
Acta Physiol Scand Suppl; 2002 Feb; 648():1-55. PubMed ID: 11913222
[TBL] [Abstract][Full Text] [Related]
7. A selective cysteinyl leukotriene receptor 2 antagonist blocks myocardial ischemia/reperfusion injury and vascular permeability in mice.
Ni NC; Yan D; Ballantyne LL; Barajas-Espinosa A; St Amand T; Pratt DA; Funk CD
J Pharmacol Exp Ther; 2011 Dec; 339(3):768-78. PubMed ID: 21903747
[TBL] [Abstract][Full Text] [Related]
8. Receptor preferences of cysteinyl-leukotrienes in the guinea pig lung parenchyma.
Sakata K; Bäck M
Eur J Pharmacol; 2002 Feb; 436(1-2):119-26. PubMed ID: 11834255
[TBL] [Abstract][Full Text] [Related]
9. Characterization of the human cysteinyl leukotriene 2 receptor.
Heise CE; O'Dowd BF; Figueroa DJ; Sawyer N; Nguyen T; Im DS; Stocco R; Bellefeuille JN; Abramovitz M; Cheng R; Williams DL; Zeng Z; Liu Q; Ma L; Clements MK; Coulombe N; Liu Y; Austin CP; George SR; O'Neill GP; Metters KM; Lynch KR; Evans JF
J Biol Chem; 2000 Sep; 275(39):30531-6. PubMed ID: 10851239
[TBL] [Abstract][Full Text] [Related]
10. GPR17 is a negative regulator of the cysteinyl leukotriene 1 receptor response to leukotriene D4.
Maekawa A; Balestrieri B; Austen KF; Kanaoka Y
Proc Natl Acad Sci U S A; 2009 Jul; 106(28):11685-90. PubMed ID: 19561298
[TBL] [Abstract][Full Text] [Related]
11. Leukotriene E4: perspective on the forgotten mediator.
Lee TH; Woszczek G; Farooque SP
J Allergy Clin Immunol; 2009 Sep; 124(3):417-21. PubMed ID: 19482346
[TBL] [Abstract][Full Text] [Related]
12. A kinetic binding study to evaluate the pharmacological profile of a specific leukotriene C(4) binding site not coupled to contraction in human lung parenchyma.
Ravasi S; Capra V; Mezzetti M; Nicosia S; Rovati GE
Mol Pharmacol; 2000 Jun; 57(6):1182-9. PubMed ID: 10825389
[TBL] [Abstract][Full Text] [Related]
13. Cysteinyl leukotriene 2 receptor on dendritic cells negatively regulates ligand-dependent allergic pulmonary inflammation.
Barrett NA; Fernandez JM; Maekawa A; Xing W; Li L; Parsons MW; Austen KF; Kanaoka Y
J Immunol; 2012 Nov; 189(9):4556-65. PubMed ID: 23002438
[TBL] [Abstract][Full Text] [Related]
14. Leukotriene E4 activates peroxisome proliferator-activated receptor gamma and induces prostaglandin D2 generation by human mast cells.
Paruchuri S; Jiang Y; Feng C; Francis SA; Plutzky J; Boyce JA
J Biol Chem; 2008 Jun; 283(24):16477-87. PubMed ID: 18411276
[TBL] [Abstract][Full Text] [Related]
15. Pharmacological differences among CysLT(1) receptor antagonists with respect to LTC(4) and LTD(4) in human lung parenchyma.
Ravasi S; Capra V; Panigalli T; Rovati GE; Nicosia S
Biochem Pharmacol; 2002 Apr; 63(8):1537-46. PubMed ID: 11996896
[TBL] [Abstract][Full Text] [Related]
16. The murine cysteinyl leukotriene 2 (CysLT2) receptor. cDNA and genomic cloning, alternative splicing, and in vitro characterization.
Hui Y; Yang G; Galczenski H; Figueroa DJ; Austin CP; Copeland NG; Gilbert DJ; Jenkins NA; Funk CD
J Biol Chem; 2001 Dec; 276(50):47489-95. PubMed ID: 11591709
[TBL] [Abstract][Full Text] [Related]
17. Cysteinyl leukotriene receptor assays.
Muccitelli RM; Luttmann MA; Hay DW
Curr Protoc Pharmacol; 2001 May; Chapter 4():Unit 4.16. PubMed ID: 22293965
[TBL] [Abstract][Full Text] [Related]
18. Identification of GPR99 protein as a potential third cysteinyl leukotriene receptor with a preference for leukotriene E4 ligand.
Kanaoka Y; Maekawa A; Austen KF
J Biol Chem; 2013 Apr; 288(16):10967-72. PubMed ID: 23504326
[TBL] [Abstract][Full Text] [Related]
19. Cysteinyl leucotriene receptor type 1 mediates contraction in human and guinea-pig oesophagus.
Chang BS; Chang JC; Wang YS; Huang SC
Neurogastroenterol Motil; 2008 Oct; 20(10):1140-6. PubMed ID: 18651869
[TBL] [Abstract][Full Text] [Related]
20. Molecular cloning and characterization of a second human cysteinyl leukotriene receptor: discovery of a subtype selective agonist.
Nothacker HP; Wang Z; Zhu Y; Reinscheid RK; Lin SH; Civelli O
Mol Pharmacol; 2000 Dec; 58(6):1601-8. PubMed ID: 11093801
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
